Measured Wealth Private Client Group, LLC Supernus Pharmaceuticals, Inc. Transaction History

Measured Wealth Private Client Group, LLC

  • $307 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020
SELL
$17.09 - $24.89 $272,431 - $396,771
-15,941 Closed
0 $0
Q1 2020

Apr 22, 2020
BUY
$14.45 - $24.69 $53,826 - $91,970
3,725 Added 30.49%
15,941 $287,000
Q4 2019

Jan 15, 2020
BUY
$19.93 - $29.13 $243,464 - $355,852
12,216 New
12,216 $290,000

Others Institutions Holding SUPN

# of Institutions
290
Shares Held
60.7M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.05B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Measured Wealth Private Client Group, LLC Portfolio

Follow Measured Wealth Private Client Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email